Appili Therapeutics Inc.
APLI.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.15M | -1.84M | -1.66M | -1.92M | -2.90M |
| Total Depreciation and Amortization | 7.20K | 10.10K | 9.80K | 9.70K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 943.30K | 1.40M | 1.79M | 2.66M | 2.12M |
| Change in Net Operating Assets | 1.16M | 273.70K | 565.70K | -143.00K | 319.80K |
| Cash from Operations | -36.00K | -151.30K | 699.90K | 608.00K | -451.30K |
| Capital Expenditure | 0.00 | -500.00 | -1.70K | -1.70K | -1.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -500.00 | -1.70K | -1.70K | -1.20K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 400.00K | 400.00K |
| Total Debt Repaid | -104.90K | -131.90K | -128.40K | -141.90K | -122.30K |
| Issuance of Common Stock | 177.50K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -104.10K | -89.70K | -58.70K | -64.50K | -74.20K |
| Cash from Financing | -22.20K | -158.40K | -133.70K | 144.20K | 148.70K |
| Foreign Exchange rate Adjustments | 48.60K | 55.90K | 11.70K | 51.40K | 2.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.70K | -254.40K | 576.10K | 801.80K | -301.40K |